financetom
Business
financetom
/
Business
/
UK's CMA launches formal probe into Carlsberg-Britvic deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK's CMA launches formal probe into Carlsberg-Britvic deal
Oct 23, 2024 3:05 AM

*

CMA sets Dec 18 deadline for Phase 1 decision

*

Carlsberg says CMA investigation is normal process,

Britvic ( BTVCF )

declines comment

(Adds background in paragraph 3, Britvic's ( BTVCF ) response in

paragraph 6)

Oct 23 (Reuters) - Britain's Competition and Markets

Authority(CMA) launched a formal investigation into Carlsberg's

3.3 billion pounds ($4.28 billion) deal with Britvic ( BTVCF )

, the regulator said on Wednesday.

Carlsberg struck a deal to acquire the British soft drinks

maker in July aiming to establish a UK beverage "powerhouse".

The deal includes the Danish brewer taking over Britvic's ( BTVCF )

bottling agreement with PepsiCo ( PEP ). Carlsberg already

bottles PepsiCo ( PEP ) drinks in several markets and sees potential to

expand into additional geographies in the future.

The regulator has set a deadline of Dec. 18 for its Phase 1

decision and said it is assessing whether the deal is expected

to result in a substantial reduction in competition in any

market in the United Kingdom for goods or services.

"This is a normal process that was expected, and we look

forward to working constructively with the CMA as it

progresses," a Carlsberg spokesperson said in an emailed

statement.

Britvic ( BTVCF ) declined to comment.

($1 = 0.7701 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
BRIEF-Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Nov 4, 2025
Nov 4 (Reuters) - Evoke Pharma Inc ( EVOK ): * EVOKE PHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY QOL MEDICAL * EVOKE PHARMA INC ( EVOK ): PROPOSED DEAL FOR FOR $11.00 PER SHARE IN CASH AT CLOSING Source text: Further company coverage: ...
Wingstop Q3 system-wide sales rise 10%, helped by new restaurants
Wingstop Q3 system-wide sales rise 10%, helped by new restaurants
Nov 4, 2025
Overview * Wingstop ( WING ) fiscal Q3 system-wide sales rise 10% to $1.4 bln * Adjusted EBITDA for fiscal Q3 grows 18.6% to $63.7 mln, highest quarter on record * Company opened 114 net new restaurants, achieving 19.3% net new unit growth Outlook * Wingstop ( WING ) revises 2025 domestic same store sales growth to decline 3%-4% *...
Nuvectis Pharma Q3 net loss widens
Nuvectis Pharma Q3 net loss widens
Nov 4, 2025
Overview * Nuvectis Q3 net loss widens to $7.5 mln, driven by milestone and study costs * Cash position improves to $35.4 mln, supported by public offering and ATM facility * NXP900 Phase 1b program initiated, showcasing therapeutic potential in advanced cancers Outlook * Cash runway expected to support operations into 3Q-2027 Result Drivers * Research and development expenses were...
Hillman Q3 net sales rise 8%, beat estimates
Hillman Q3 net sales rise 8%, beat estimates
Nov 4, 2025
Overview * Hillman Q3 2025 net sales rise 8% to record $424.9 mln, beating analyst expectations * Adjusted EPS for Q3 2025 beats consensus, reaching $0.22 per share * Company repurchased 325.6 thousand shares, totaling $3.2 mln Outlook * Hillman maintains FY 2025 net sales guidance at $1.535 to $1.575 bln * Company raises FY 2025 adjusted EBITDA guidance to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved